Lineage Cell Therapeutics (LCTX)
(Delayed Data from AMEX)
$1.14 USD
+0.03 (2.70%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.13 -0.01 (-0.88%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.04 | 0.00% |
Earnings Summary
For their last quarter, Lineage Cell Therapeutics (LCTX) reported earnings of -$0.03 per share, beating the Zacks Consensus Estimate of $-0.07 per share. This reflects a positive earnings surprise of 57.14%. Look out for LCTX's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.04 per share, reflecting a year-over-year decrease of 33.33%.
Earnings History
Price & Consensus
Zacks News for LCTX
Lineage Cell (LCTX) Reports Q2 Loss, Tops Revenue Estimates
LCTX: What are Zacks experts saying now?
Zacks Private Portfolio Services